Skip to content

Clinical trials

Phase 2 Bronchiolitis Obliterans Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiolitis Obliterans Syndrome Phase: Phase 2 Country / region: United States Clear all

76 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20031
20043
20064
20072
20086
20092
20103
20116
20123
20131
20142
20156
20163
20171
20182
20191
20203
20214
20221
20234
20247
20256
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Terminated16
Recruiting14
Unknown status3
Active, not recruiting2
Withdrawn2
Enrolling by invitation1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Dana-Farber Cancer Institute6
Fred Hutchinson Cancer Center6
Novartis Pharmaceuticals5
National Cancer Institute (NCI)4
Gilead Sciences3
Incyte Corporation3
Northside Hospital, Inc.3
Dey2
Eli Lilly and Company2
Kadmon, a Sanofi Company2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiolitis Obliterans Syndrome76
Leukemia9
Graft vs Host Disease8
Leukemia, Lymphocytic, Chronic, B-Cell6
Bronchiolitis Obliterans4
Hepatitis C3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive3
Lymphoma, Follicular3
Pain3
Pulmonary Disease, Chronic Obstructive3

Trials

Showing 1 to 25 of 76. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.